Journal
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
Volume 332, Issue 4, Pages 1237-1244Publisher
SPRINGER
DOI: 10.1007/s10967-022-08741-z
Keywords
SPECT/MRI; iron oxide nanoparticles; Dual-modality imaging; Tumor targeting
Ask authors/readers for more resources
Multimodal imaging is a growing trend in molecular imaging. In this study, a SPECT/MRI dual-modality probe was developed using superparamagnetic iron oxide nanoparticles. The nanoparticles were functionalized using RGDyk peptide and DTPA chelator. In vivo SPECT imaging and T2-weighted MR imaging on tumor-bearing mice demonstrated the targeting of the probe, indicating the potential of the SPECT/MRI dual-modality probe for tumor evaluation and diagnosis.
Multimodal imaging has become a trend in the development of molecular imaging. For SPECT/MRI dual-modality imaging, we developed a SPECT/MRI dual-modality probe based on superparamagnetic iron oxide nanoparticles. RGDyk peptide and DTPA chelator were used to realize the functionalization of nanoparticles. Both SPECT imaging and T2-weighted MR imaging in vivo on 4T1 tumor-bearing mice showed targeting of the probe, demonstrating the potential of the SPECT/MRI dual-modality probe as a tool for tumor evaluation and diagnosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available